These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36950134)

  • 1. Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors.
    Yang F; Ni B; Lian Q; Qiu X; He Y; Zhang Q; Zou X; He F; Chen W
    Front Genet; 2023; 14():1066410. PubMed ID: 36950134
    [No Abstract]   [Full Text] [Related]  

  • 2. Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.
    Liu B; Wang X; Wu N; Liu F; Rao H
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38409698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
    Cai C; Song X; Yu C
    Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].
    Lin YX; Chen K; An FM; Wang YF; Wu XB; Zhan Q; Zhang GQ
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1006-1013. PubMed ID: 34814397
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Chen T; Zhang S; Zhou D; Lu P; Mo X; Tamrakar R; Yang X
    Front Oncol; 2022; 12():911808. PubMed ID: 36033523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.
    Zeng T; Chen G; Qiao X; Chen H; Sun L; Ma Q; Li N; Wang J; Dai C; Xu F
    Front Pharmacol; 2022; 13():823140. PubMed ID: 35431924
    [No Abstract]   [Full Text] [Related]  

  • 9. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
    Lewinska M; Santos-Laso A; Arretxe E; Alonso C; Zhuravleva E; Jimenez-Agüero R; Eizaguirre E; Pareja MJ; Romero-Gómez M; Arrese M; Suppli MP; Knop FK; Oversoe SK; Villadsen GE; Decaens T; Carrilho FJ; de Oliveira CP; Sangro B; Macias RIR; Banales JM; Andersen JB
    EBioMedicine; 2021 Nov; 73():103661. PubMed ID: 34740106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
    Nguyen XK; Zhang J; Chin KL; Bloom S; Nicoll AJ
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
    Wong SW; Ting YW; Chan WK
    JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.
    Chen J; Song S; Li X; Bian D; Wu X
    Saudi J Gastroenterol; 2022; 28(2):92-100. PubMed ID: 34810377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.
    David D; Raghavendran A; Goel A; Bharath Kumar C; Kodiatte TA; Burad D; Abraham P; Ramakrishna B; Joseph P; Ramachandran J; Eapen CE
    Indian J Gastroenterol; 2017 Sep; 36(5):373-379. PubMed ID: 28975595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis.
    Zhang G; Hou Y
    World J Surg Oncol; 2022 Nov; 20(1):364. PubMed ID: 36397165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAFLD and MAFLD as emerging causes of HCC: A populational study.
    Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
    JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.
    Tokushige K; Hyogo H; Nakajima T; Ono M; Kawaguchi T; Honda K; Eguchi Y; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Suzuki Y; Kogiso T; Karino Y; Munekage K; Kuromatsu R; Oeda S; Yanase M; Mori K; Ogawa Y; Seko Y; Takehara T; Itoh Y; Nakajima A; Kanemasa K; Nishino K; Masaki N; Takahashi H; Seike M; Torimura T; Saibara T; Toyota J; Chayama K; Hashimoto E
    J Gastroenterol; 2016 Jun; 51(6):586-96. PubMed ID: 26456168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.